Mkt Up, Stem Cells Down Tuesday 9.22 - BSDM up 103%
Tuesday 9.22.09:
DOW +51(.5%) @9,830..NAS +8.26(.39%) @2,146..SP500 +7(.66%) @1,072
BIO-Stem Index:-.69(.46%) @148.95 (+48.95% ytd)
BIO-ETF Index:-1.55(-1.32%) @115.93 (+15.93% ytd)
[Stem cell index beating biotech by 28.4%]
Tuesday the market regained Monday's slight drop, with all 3 indices up about a half percent. Stem cells reversed yesterday's count, 12 up and 19 down. The big news was BSD Medical (BSDM), up 103%, which had positive results on ovarian tumors with their devices that use heat and electromagnetic waves along with traditional chemo, and 38% of the patients showed improvement in a Phase 3 trial. We bought some late in the day after price settled back down to 3.83 at the close. the Reuters story here..
CelSci (CVM) didn't give back much today, just 2.6%, considering it's recent run due to its more general flu vaccine, and government interest. Today, stem cell index didn't fall but 1/3 as much as the biotech ETFs, which gave back yesterday's gain.
Stem Cell Stocks (12 up, 19 down)
Big Winners:CYTX +11.5%, DGX 3.4%, OSTE +3%,
Losers: ARIA -6.1%, CUR 5.8%, OPXA -4.2%
Swine Flu Stocks
AVII +1.1%, BCRX -4.2%, DVAX -6.5%, GILD -1.1%, INHX +4.35%, INO -2.2%, NVAX -4%, SIGA -1.7%, SVA -1.9%
Other Flu: APT -5.6%, CVM -2.6%, PURE +4.1%
Other Biotech
Big Winners: BSDM +104%, ANIK +5.4%, NKTR +9.4%, PARD +6.4%
Losers: DYAX -6.5%, KVA -5.5%, ONCY -11.1%, ONXX -3.4% (may have a legal fight with partner Bayer over a similar drug to theirs), PDLI -3.8%, PGNX -3.6%, RPRX -8%, SGMO -3.5%, SOMX -5.5%, THRX -4.1%
SubMicro: CEGE +9.1%, CPRX +4.2%, FMTI +9%, GETA +12%, HEPH -4.6%, ICAD +5.9%, RGN -6.8%, TGEN +15.5%, TRBN -7.2%, TRMS +6.5%, YMI +3.6%
Volume Up vs Daily Avg: CUR, DGX, DNDN, OSIR, CVM, ADLR, ALTH, BDSM (55x, 11m shrs, half its float), CRME, GSK, NKTR, PDLI, VVUS, WYE, GETA, KOOL
New Intraday Highs:ALXN, DNDN, CVM, SNY, EXEL, MED, MRX, NKTR, SGEN, GETA, PCYC
Disclosure: Long BSDM, CVM, KERX




0 comments:
Post a Comment